Incidence and mortality of adult respiratory distress syndrome: a prospective analysis from a large metropolitan hospital.

Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Incidence and mortality of adult respiratory distress syndrome: a prospective analysis from a large metropolitan hospital.

Crit Care Med. 1986 Jan;14(1):1-4. Unique Identifier : AIDSLINE MED/86080764
Baumann WR; Jung RC; Koss M; Boylen CT; Navarro L; Sharma OP

Abstract: We examined the incidence and mortality of adult respiratory distress syndrome (ARDS) in patients receiving emergency medical care at a large metropolitan medical center. The patients were classified into eight high-risk categories and monitored prospectively until discharge or death. Over a period of 12 months, 11,112 such patients entered the emergency room. Of 4926 who were admitted to the hospital acutely ill, 90 (2%) developed ARDS. Thirty-six percent of these survived. ARDS occurred in 25% of patients admitted with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia, and mortality in these patients was 86%. Aspiration pneumonia was the primary cause of ARDS in 37% of the patients, who also had a similar mortality rate (85%). Mortality was also high in patients with multisystem organ failure or with ARDS and disseminated intravascular coagulation. These results indicate that there probably is a relatively low incidence of ARDS among hospital patients admitted with high-risk diagnoses.

Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS Adult Aged California Disseminated Intravascular Coagulation/COMPLICATIONS Female Human Male Middle Age Pneumonia, Aspiration/COMPLICATIONS Pneumonia, Pneumocystis carinii/COMPLICATIONS Prospective Studies Respiratory Distress Syndrome, Adult/*EPIDEMIOLOGY/ETIOLOGY/ MORTALITY JOURNAL ARTICLE

860430
M8640116

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .